Real-world early- to midterm outcomes of aortic valve replacement using novel tissue technology bioprosthesis at a high-volume centerCentral MessagePerspective

Objective: The INSPIRIS-RESILIA aortic valve (Edwards Lifesciences) uses a novel tissue-fixation technology to enhance the bioprosthesis's longevity. We sought to report midterm INSPIRIS-RESILIA aortic bioprosthesis performance in a large contemporary cohort at a single institution. Methods: Between...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Emily Vianna, MD, Patrick R. Vargo, MD, L. Leonardo Rodriguez, MD, Salvatore Poddi, MD, Kelsey Curran, MPH, Jeevanantham Rajeswaran, PhD, Shinya Unai, MD, Eric E. Roselli, MD, Lars G. Svensson, MD, PhD, Haytham Elgharably, MD, PhD
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2026-04-01
סדרה:	JTCVS Open
נושאים:	INSPIRIS-RESILIA AVR SVD bioprosthesis
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2666273626000409
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!